Uncoupling of mTORC1 from E2F activity maintains DNA damage and senescence

Leighton H Daigh1, Debarya Saha2, David L Rosenthal2

  • 1Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA.

Nature Communications
|October 25, 2024
PubMed

Insights

Cellular senescence, linked to aging, involves persistent DNA damage. This study reveals mTORC1 signaling drives DNA damage in non-proliferating cells, while E2F activation repairs it, offering anti-aging insights.

Area of Science:

  • Molecular Biology
  • Cellular Aging
  • Genetics

Background:

  • Cellular senescence, a state of irreversible cell cycle arrest, is a hallmark of organismal aging.
  • DNA damage is a known trigger for senescence, but mechanisms maintaining DNA damage in non-proliferating senescent cells are unclear.
  • Understanding senescence is crucial for developing anti-aging therapies.

Purpose of the Study:

  • To investigate the mechanisms by which senescent cells maintain DNA damage.
  • To explore the role of mTORC1 signaling and E2F transcriptional program in senescence.
  • To identify potential targets for anti-aging interventions.

Main Methods:

  • Utilized reversible expression of p16INK4 (p16), a senescence-inducing protein.
  • Employed live single-cell analysis to monitor cellular processes.
  • Investigated the interplay between mTORC1 signaling, DNA damage, inflammation, and E2F activity.

Main Results:

  • Sustained mTORC1 signaling induces senescence in non-proliferating cells by increasing persistent transcriptional DNA damage and inflammation.
  • This damage and inflammation signaling remain even after the senescence inducer (p16) is degraded.
  • Activation of the E2F transcriptional program repairs transcriptionally damaged DNA independently of DNA replication.

Conclusions:

  • Senescence can be perpetuated by ongoing mTORC1-driven transcriptional DNA damage.
  • The E2F transcriptional program plays a critical role in repairing this damage.
  • Targeting mTORC1 and E2F pathways may offer novel anti-aging therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
DNA Damage Can Stall the Cell Cycle02:37

DNA Damage Can Stall the Cell Cycle

2.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K